Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Pros and cons of implementing a carrier genetic test in an infertility practice

Gil-Arribas, Elisa; Herrer, Raquel; Serna, José

Current Opinion in Obstetrics and Gynecology: June 2016 - Volume 28 - Issue 3 - p 172–177
doi: 10.1097/GCO.0000000000000272
FERTILITY, IVF AND REPRODUCTIVE GENETICS: Edited by Emre Seli and Juan Antonio García Velasco

Purpose of review Carrier screening is promptly evolving thanks to the rapid development of new technologies and mutation knowledge. Expanded carrier screening is already being used in assisted reproduction. Medical, ethical, psychological and legal aspects appear from the general public, patients, healthcare providers and scientific societies. Pros and cons of implementing this technique are highlighted.

Recent findings Recent publications show the development of wider gene screening panels with lowering cost. Human genome is continually being updated as are the number of mutations and their corresponding phenotype known. Classical criteria established to consider a genetic screening protocol are nowadays overtaken, and scientific societies are developing guidelines and criteria adapted to expanded genetic testing. There is no universal agreement on the mutations that should be included in the panel. Patients’ perceptions on carrier genetic testing seem to be positive. Counselling patients is of paramount importance stressing implications when testing positive on their clinical decision making. Gamete donor genetic testing implies a modified approach and blinded matching must be offered.

Summary There are important positive aspects implementing a carrier genetic test in assisted reproductive technique, but controversial issues appear. Reproductive providers must be appropriately aware and follow the new guidelines.

IVI-Zaragoza, Zaragoza, Spain

Correspondence to José Serna, MD, PhD, IVI-Zaragoza, María Zambrano 31, bajo. 50018 Zaragoza, Spain. Tel: +34 976 093 560; e-mail:

Copyright © 2016 YEAR Wolters Kluwer Health, Inc. All rights reserved.